Adenovirus Serotype 5 Neutralizing Antibodies Target both Hexon and Fiber following Vaccination and Natural Infection
Open Access
- 1 January 2012
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 86 (1), 625-629
- https://doi.org/10.1128/jvi.06254-11
Abstract
The immunogenicity of adenovirus serotype 5 (Ad5) vectors has been shown to be suppressed by neutralizing antibodies (NAbs) directed primarily against the hexon hypervariable regions (HVRs). However, the role of NAbs directed against other capsid components, particularly the adenovirus fiber, remains unclear. Here we show that Ad5 NAbs target both hexon and fiber following vaccination and natural infection. Utilizing neutralization assays with capsid chimeric vectors, we observed that NAb responses to hexon appeared dominant and NAb responses against fiber were subdominant in sera from vaccinated mice, vaccinated humans, and naturally exposed humans. A novel chimeric Ad5 vector in which both the hexon HVRs and the fiber knob were exchanged nearly completely evaded Ad5-specific NAbs both in vitro and in vivo .This publication has 16 references indexed in Scilit:
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsVaccine, 2011
- Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or ImmunizationJournal of Virology, 2010
- Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansNature Medicine, 2009
- Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy AdultsClinical Infectious Diseases, 2008
- Modulation of DNA Vaccine-Elicited CD8 + T-Lymphocyte Epitope Immunodominance HierarchiesJournal of Virology, 2006
- Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan AfricaEmerging Infectious Diseases, 2006
- Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunityNature, 2006
- Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus ImmunityJournal of Virology, 2003
- Hexon Gene Switch Strategy for the Generation of Chimeric Recombinant AdenovirusHuman Gene Therapy, 2002
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002